Skip to main content
. 2021 Nov 16;13(11):1936. doi: 10.3390/pharmaceutics13111936
API Active Pharmaceutical Ingredient
cDPI Capsule-based Dry Powder Inhaler
COPD Chronic Obstructive Pulmonary Disease
DPI Dry Powder Inhaler
FPD Fine Particle Dose
HPMC hydroxypropyl methylcellulose
ICS inhaled chorticosteroids
LABA Long-acting beta(2) agonist
LAMA Long-acting muscarinic antagonist
pMDI Pressurised Metered Dose Inhaler